Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Molecular Cancer Therapeutics|December 17, 2002
Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicityMikhail V Blagosklonny, Robert Robey, Dan L Sackett, et al.
Mutation Research|July 14, 2009
gammaH2AX: A potential DNA damage response biomarker for assessing toxicological risk of tobacco productsAnthony P Albino, Ellen D Jorgensen, Patrick Rainey, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effectKhosrow Kashfi, Yassir Rayyan, Leon L Qiao, et al.
Cell Cycle (Georgetown, Tex.)|May 5, 2009
DNA damage response as a biomarker in treatment of leukemiasH Dorota Halicka, M Fevzi Ozkaynak, Oya Levendoglu-Tugal, et al.
Biochemical Pharmacology|May 28, 2004
NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?Raymond K Yeh, Jie Chen, Jennie L Williams, et al.
Cancer Biology & Therapy|December 22, 2009
DNA damage signaling is activated during cancer progression in human colorectal carcinomaKazuhito Oka, Toshiki Tanaka, Tadahiko Enoki, et al.
Pageof 7